Phytozine Ringworm Treatment Ointment
Product Images NDC 71229-101

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Phytozine Ringworm Treatment (NDC 71229-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by The Sisquoc Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Insert Phytozine '17 (Insert Phytozine 17)

This is a detailed drug facts panel for PHYTOZINE Ringworm Treatment Maximum Strength ointment, featuring sections on what ringworm is, why to use the product, treatment duration, directions, and warnings. It lists Tolnaftate (1%) as the active ingredient and includes a comprehensive list of inactive ingredients. The label also provides use instructions, precautions, and manufacturer contact information for Sisquoc Healthcare, Inc.*

FDA Label Image

Label Phytozine Retail Proof 1-17 (Label Phytozine Retail Proof 1 17)

Drug facts panel for PHYTOZINE RINGWORM TREATMENT MAXIMUM STRENGTH ointment with 1% Tolnaftate. It includes active ingredient details, usage instructions, warnings, directions for use, storage conditions (20° to 25°C), and distributor information for Sisquoc Healthcare, Inc., Newport Beach, CA. The panel provides guidance on application, safety precautions, and product effectiveness.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.